1. Home
  2. GBX vs BHVN Comparison

GBX vs BHVN Comparison

Compare GBX & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenbrier Companies Inc. (The)

GBX

Greenbrier Companies Inc. (The)

N/A

Current Price

$52.35

Market Cap

1.6B

Sector

Industrials

ML Signal

N/A

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

N/A

Current Price

$8.38

Market Cap

1.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GBX
BHVN
Founded
1974
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Railroads
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
1996
2022

Fundamental Metrics

Financial Performance
Metric
GBX
BHVN
Price
$52.35
$8.38
Analyst Decision
Sell
Buy
Analyst Count
2
14
Target Price
$49.00
$28.85
AVG Volume (30 Days)
205.9K
1.9M
Earning Date
04-07-2026
03-02-2026
Dividend Yield
2.55%
N/A
EPS Growth
28.02
26.08
EPS
1.14
N/A
Revenue
$3,240,200,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.64
N/A
P/E Ratio
$44.02
N/A
Revenue Growth
N/A
N/A
52 Week Low
$37.77
$7.48
52 Week High
$59.19
$31.18

Technical Indicators

Market Signals
Indicator
GBX
BHVN
Relative Strength Index (RSI) 44.71 26.55
Support Level $44.64 $7.48
Resistance Level $54.15 $15.66
Average True Range (ATR) 1.41 0.61
MACD -0.41 -0.14
Stochastic Oscillator 39.02 4.37

Price Performance

Historical Comparison
GBX
BHVN

About GBX Greenbrier Companies Inc. (The)

Greenbrier Companies Inc supplies equipment and services to international freight transportation markets, designing and marketing freight railcars in North America, Europe, and Brazil through subsidiaries and joint ventures. It provides railcar wheel services, parts, maintenance, and conversion services in North America. The company owns a lease fleet sourced mainly from its manufacturing operations and offers railcar management, regulatory compliance, and leasing services to railroads and owners. It operates two segments: Manufacturing and Leasing & Fleet Management, with the majority of revenue from Manufacturing. The company operates in the U.S. and internationally, with the majority of revenue from the U.S. market.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

Share on Social Networks: